Upcoming event

Chief Editor

Roderick van den Bergh

Dr. Roderick van den Bergh

Dr. Roderick van den Bergh is a urologist working at St Antonius Hospital in the Utrecht area in The Netherlands. His main areas of expertise are prostate and bladder cancer, performing robotic prostatectomy and cystectomy. His career in urology started with a PhD within the European Randomized Study of Screening for Prostate Cancer (ERSPC) in Rotterdam on active surveillance for low-risk prostate cancer (under Profs. Bangma and Schröder), where he worked on the PRIAS study (Prostate Cancer Research International: Active Surveillance).

After his urology training, Van den Bergh did a clinical fellowship in robotic urology in Melbourne, Australia (Profs. Costello and Murphy), followed by a year at the Netherlands Cancer Institute (Profs. Horenblas and Van der Poel). He is involved in the EAU Prostate Cancer Guidelines Panel, the European School of Urology, and Young Academic Urologists (YAU) Prostate Cancer Working Group. He has published over 80 Pubmed-cited articles.

Associate Editor

Igor Tsaur

Prof Tsaur

Prof. Igor Tsaur is a urologist working at the University Medicine Mainz, Germany. After medical school at the University of Wuerzburg, he completed a clinical fellowship at its Department of General Surgery, and a research fellowship in the translational research lab of the University of Frankfurt Department of Urology. His main areas of clinical expertise are robotic and open surgery of the whole spectrum of genitourinary malignancies, as well as oncologic clinical trials and systemic treatment of advanced diseases.

Tsaur’s scientific research focus is prostate and penile cancer. He is involved in the EAU Young Academic Urologists (YAU) Prostate Cancer Working Group and the Urologic Research working committee of the German Society of Urology (DGU). He has published 96 Pubmed-cited articles and received multiple awards and grants including the Prostate Cancer Research Award of the DGU as well as funding by the German Research Foundation (DFG).

Associate Editor

Constance Thibault

Dr. Constance Thibault is a medical oncologist working at the European Georges Pompidou Hospital in Paris, France. After medical school and residency at Université de Paris, she specialised in the management of genitourinary malignancies. Her main areas of clinical expertise are bladder, prostate, and kidney cancers.

With regards to research, Dr. Thibault has gained an MSc from Université Paris-Saclay in 2013. She is currently a PhD student conducting translational research projects on bladder and prostate cancers. She is also a renowned trialist involved in many academic and pharmaceutical studies, leading her to join the faculty of the ESMO (European Society of Medical Oncology) Prostate group. In addition, Dr. Thibault is an active member of the GETUG (Groupe d’Etudes des Tumeurs Uro-Génitales) providing guidance for the development of innovative trials in the onco-urology field. She has published over 50 peer-reviewed articles.